Annovis Financial Statements From 2010 to 2022

ANVS -  USA Stock  

USD 13.04  0.49  3.62%

Annovis Bio financial statements provide useful quarterly and yearly information to potential Annovis Bio investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Annovis Bio financial statements helps investors assess Annovis Bio's valuation, profitability, and current liquidity needs.
There are over fourty-one available fundamental signals for Annovis Bio, which can be analyzed over time and compared to other ratios. Please make sure to validate Annovis Bio's prevailing fundamental performance against the performance between 2010 and 2022 to make sure the trends are evolving in the right direction.
Annovis Bio Tangible Asset Value is relatively stable at the moment as compared to the past year. Annovis Bio reported last year Tangible Asset Value of 9.34 Million. As of 01/23/2022, Working Capital is likely to grow to about 9.4 M, while Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop (5 M).

Annovis Financial Statements 

 
Refresh
Check Annovis Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Annovis main balance sheet or income statement drivers, such as Interest Expense of 58.6 K, Operating Expenses of 8.2 M or Research and Development Expense of 3.8 M, as well as many exotic indicators such as Book Value per Share of 1.48, Current Ratio of 17.42 or Debt to Equity Ratio of 0.0955. Annovis financial statements analysis is a perfect complement when working with Annovis Bio Valuation or Volatility modules. It can also supplement various Annovis Bio Technical models. Please continue to the analysis of Annovis Bio Correlation against competitors.

Annovis Bio Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets10.1 M9.3 M2.2 M
Increasing
Slightly volatile
Cash and Equivalents10 M9.3 M2.1 M
Increasing
Slightly volatile
Trade and Non Trade Receivables657.7 K661.6 K723.5 K
Decreasing
Slightly volatile
Trade and Non Trade Payables524.2 K393.1 K239.1 K
Increasing
Slightly volatile
Total Liabilities682.6 K665.1 K742.6 K
Increasing
Stable
Shareholders Equity9.4 M8.7 M(4 M)
Increasing
Slightly volatile
Current Assets10.1 M9.3 M2.2 M
Increasing
Slightly volatile
Assets Non Current330.7 K332.6 K363.8 K
Decreasing
Slightly volatile
Current Liabilities959.3 K665.1 K717.3 K
Increasing
Slightly volatile
Liabilities Non Current542 K545.2 K596.2 K
Decreasing
Slightly volatile
Total Debt447.2 K449.8 K491.9 K
Decreasing
Slightly volatile
Debt Non Current447.2 K449.8 K491.9 K
Decreasing
Slightly volatile
Shareholders Equity USD9.4 M8.7 M(4 M)
Increasing
Slightly volatile
Cash and Equivalents USD10 M9.3 M2.1 M
Increasing
Slightly volatile
Total Debt USD447.2 K449.8 K491.9 K
Decreasing
Slightly volatile

Annovis Bio Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General and Administrative Expense4.4 M4.1 M1.4 M
Increasing
Slightly volatile
Research and Development Expense3.8 M3.5 M933.6 K
Increasing
Slightly volatile
Operating Expenses8.2 M7.6 M2.3 M
Increasing
Slightly volatile
Interest Expense58.6 K54.3 K9.1 K
Increasing
Slightly volatile
Weighted Average Shares7.8 M7.3 M1.9 M
Increasing
Slightly volatile
Weighted Average Shares Diluted7.8 M7.3 M1.9 M
Increasing
Slightly volatile

Annovis Bio Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Cash Flow from Financing14.9 M13.9 M3.3 M
Increasing
Slightly volatile
Issuance Repayment of Debt Securities 474.2 K477 K521.6 K
Decreasing
Slightly volatile
Issuance Purchase of Equity Shares14.9 M13.9 M4.1 M
Increasing
Slightly volatile
Net Cash Flow or Change in Cash and Cash Equivalents10 M9.3 M1.9 M
Increasing
Slightly volatile
Share Based Compensation2.3 M2.1 M544.4 K
Increasing
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Return on Average Equity(0.55)(0.53)(0.0339)
Decreasing
Slightly volatile
Return on Invested Capital21.0926.37.0798
Increasing
Slightly volatile
Price to Book Value6.166.26.7819
Decreasing
Slightly volatile
Debt to Equity Ratio0.09550.0885(0.0553)
Increasing
Slightly volatile
Current Ratio17.4216.143.752
Increasing
Slightly volatile
Book Value per Share1.481.37(20.9628)
Increasing
Slightly volatile
Tangible Assets Book Value per Share1.831.480.7848
Increasing
Slightly volatile

Annovis Bio Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Capitalization46.5 M46.8 M51.1 M
Decreasing
Slightly volatile
Enterprise Value38.6 M38.8 M42.4 M
Decreasing
Slightly volatile
Average Equity11.4 M10.6 M(3.8 M)
Increasing
Slightly volatile
Average Assets8.9 M11.3 M2.8 M
Increasing
Slightly volatile
Tangible Asset Value10.1 M9.3 M2.2 M
Increasing
Slightly volatile
Working Capital9.4 M8.7 M1.5 M
Increasing
Slightly volatile

Annovis Fundamental Market Drivers

Short Percent Of Float7.60%
Forward Price Earnings-4.71
Shares Short Prior Month525.18k
Average Daily Volume Last 10 Day90.85k
Average Daily Volume In Three Month161.64k
Date Short Interest15th of December 2021
Fifty Day Average21.58
Two Hundred Day Average41.70

Annovis Upcoming Events

Upcoming Quarterly Report2nd of March 2022
Next Fiscal Quarter End31st of December 2021

About Annovis Bio Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Annovis Bio income statement, its balance sheet, and the statement of cash flows. Annovis Bio investors use historical funamental indicators, such as Annovis Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Annovis Bio investors may use each financial statement separately, they are all related. The changes in Annovis Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Annovis Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Annovis Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Annovis Bio. Please read more on our technical analysis and fundamental analysis pages.
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania. Annovis Bio operates under Biotechnology classification in the United States and is traded on NYSEMKT Exchange. It employs 2 people.

Annovis Bio Investors Sentiment

The influence of Annovis Bio's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Annovis. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Annovis Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Annovis Bio's short interest history, or implied volatility extrapolated from Annovis Bio options trading.

Current Sentiment - ANVS

Annovis Bio Investor Sentiment

Macroaxis portfolio users are unresponsive in their sentiment towards investing in Annovis Bio. What is your sentiment towards investing in Annovis Bio? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Pair Trading with Annovis Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Annovis Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annovis Bio will appreciate offsetting losses from the drop in the long position's value.

Annovis Bio Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Annovis Bio and Brickell Biotech. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Please continue to the analysis of Annovis Bio Correlation against competitors. Note that the Annovis Bio information on this page should be used as a complementary analysis to other Annovis Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Annovis Stock analysis

When running Annovis Bio price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Is Annovis Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis Bio. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Annovis Bio is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis Bio's value that differs from its market value or its book value, called intrinsic value, which is Annovis Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis Bio's market value can be influenced by many factors that don't directly affect Annovis Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Annovis Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.